A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma

NCT02339571 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

600

Enrollment

NIH

Sponsor class

Conditions

Stage III Cutaneous Melanoma AJCC v7
Stage IV Cutaneous Melanoma AJCC v6 and v7

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography Test
BIOLOGICAL: Ipilimumab
PROCEDURE: Magnetic Resonance Elastography
PROCEDURE: Multigated Acquisition Scan
BIOLOGICAL: Nivolumab
BIOLOGICAL: Sargramostim

Sponsor

National Cancer Institute (NCI)